Email updates

Keep up to date with the latest news and content from BMC Cardiovascular Disorders and BioMed Central.

Open Access Highly Accessed Research article

Novel Toll-like receptor-4 deficiency attenuates trastuzumab (Herceptin) induced cardiac injury in mice

Nasser Ghaly Yousif* and Fadhil G Al-amran

BMC Cardiovascular Disorders 2011, 11:62  doi:10.1186/1471-2261-11-62

PubMed Commons is an experimental system of commenting on PubMed abstracts, introduced in October 2013. Comments are displayed on the abstract page, but during the initial closed pilot, only registered users can read or post comments. Any researcher who is listed as an author of an article indexed by PubMed is entitled to participate in the pilot. If you would like to participate and need an invitation, please email info@biomedcentral.com, giving the PubMed ID of an article on which you are an author. For more information, see the PubMed Commons FAQ.

use in the clinical

Joon Anderson   (2011-11-17 13:57)  Research Institute

This is a good study, but we need to confirm this result in the clinical trial, because the cardiomyopathy is a real adverse effect of trastuzumab when we used it in the treatmnet of Her2/neu positive breast cancer.
Anderson

Competing interests

None declared

top

intersting study!!

MARIA LUISE   (2011-11-17 13:53)  MD,ANDERSON CANCER CENTER email

This is agood study to explained the mechanism of trastuzumab toxicity.

Competing interests

None declared

top

Post a comment